Citadel Advisors - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 45 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$71,017
-93.4%
40,581
-84.0%
0.00%
Q4 2022$1,075,157
+3368.2%
252,978
+861.9%
0.00%
Q3 2022$31,000
-72.6%
26,300
-76.6%
0.00%
Q2 2022$113,000
+253.1%
112,443
+758.3%
0.00%
Q1 2022$32,000
-83.3%
13,100
-81.6%
0.00%
Q4 2021$192,000
-12.3%
71,193
+62.5%
0.00%
Q3 2021$219,000
-57.1%
43,800
-35.9%
0.00%
Q2 2021$510,000
+54.1%
68,318
+21.2%
0.00%
Q1 2021$331,000
+335.5%
56,391
+248.7%
0.00%
Q4 2020$76,00016,1700.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 50,714$94,8350.06%
Baker Brothers Advisors 3,140,473$5,872,6850.03%
VANCE WEALTH, INC. 39,266$73,4270.03%
CSS LLC/IL 258,814$483,9820.03%
SHELL ASSET MANAGEMENT CO 317,240$5930.02%
Steward Partners Investment Advisory, LLC 650,000$1,215,5000.02%
Alpine Global Management, LLC 30,000$56,1000.01%
HoyleCohen, LLC 74,408$139,1430.01%
BENDER ROBERT & ASSOCIATES 24,059$44,9900.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 86,212$161,2160.01%
View complete list of SUMMIT THERAPEUTICS INC shareholders